Back to search

Mechanisms of early death despite thrombolytic therapy: Experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study

Data up to Jan 2025

Published1992
Citations43
References32
Clinical Trials (1)

Total Citations Per Year

Abstract

References (32)

Statistical Methods for Rates and Proportions

2003 • 17,930 citations

Epidemiologic Research: Principles and Quantitative Methods.

1984 • 3,019 citations

急性心筋梗塞の疑いのある17187症例におけるストレプトキナーゼ静脈内投与,アスピリン経口投与,上記2つの併用または無処置の無作偽試験 ISIS-2

1988 • 2,760 citations

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

1988 • 2,740 citations

EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION

1986 • 2,315 citations

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1987 • 2,245 citations

Epidemiologic Research: Principles and Quantitative Methods.

1983 • 1,935 citations

TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION

1988 • 1,161 citations

Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction

1989 • 991 citations

A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction

1987 • 964 citations

MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction

1990 • 911 citations

Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase*

1987 • 751 citations

THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY

1988 • 669 citations

A HAEMATOLOGIST

1989 • 567 citations

HOME OR AWAY?

1964 • 508 citations

THE SIMIAN CREASE.

1964 • 464 citations

Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.

1991 • 436 citations

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.

1990 • 423 citations

Pathophysiology of Cardiogenic Shock

1973 • 317 citations

Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator

1989 • 308 citations

Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock.

1988 • 281 citations

Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: A 3 year experience

1987 • 231 citations

Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial.

1990 • 220 citations

Six- and twelve-month follow-up of the phase I thrombolysis in myocardial infarction (TIMI) trial

1988 • 209 citations

Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase.

1988 • 125 citations

The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction

1988 • 121 citations

INTENSIVE THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA AND UNFAVOURABLE PRESENTING FEATURES

1988 • 116 citations

Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease

1990 • 96 citations

Progressive nature of myocardial injury in selected patients with cardiogenic shock

1978 • 85 citations

Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: Report of an initial experience

1989 • 72 citations

[The Italian Group for the Study of Streptokinase in Myocardial Infarct: Analysis of intrahospital causes of death].

1987 • 25 citations

[Treatment of primary cardiogenic shock by coronary transluminal angioplasty during the acute phase of myocardial infarction].

1990 • 18 citations

Cited By (0)

Loading...
Mechanisms of early death despite thrombolytic therapy: Experience from the Thrombolysis… (1992) – Journal of the American College of Cardiology | Metascience Observatory Explorer